Major Shareholders

Please note that if a shareholder’s shareholding in DanCann Pharma A/S changes to the effect that the shareholder’s shares or voting rights are increased or reduced so that they exceed or fall below the 5%, 10%, 15%, 20%, 25%, 30%, one-third, 50%, two-thirds, 90% or 100% thresholds of the share capital or voting rights of DanCann Pharma A/S, the shareholder is obliged to notify DanCann Pharma A/S hereof within two (2) weeks. Such notice must be given by email sent to The notice must include information on (i) the date of acquisition of the shares, (ii) the number of shares, (iii) the shareholder’s full name and address or, in case of a business, its name, Central Business Register (CVR) number and registered office. If the shareholder is a foreign (not Danish) legal person or entity, the notice must be accompanied by other documentation ensuring clear identification of the shareholder. The notice must also state the nominal value of the shares and the voting rights attaching to them. For further information on calculation of shareholdings with respect to this duty of notification, please refer to sections 55-56 of the Danish Companies Act.


Numbers are updated on a quarterly basis (last dated 30 September 2020).

Major shareholders in the Company (more than 5 percent of the Company’s share capital):

Names of Major Shareholders

Number of Shares

Nominal value of Shares

Number of votes

Share of ownership
(In percentages)

JKR Investment Group ApS
(CEO, Jeppe Krog Rasmussen)





JJV Invest AB   





Futur Pension Forsäkringsaktiebolag